Hepatitis C virus (HCV) or B virus (HBV) Infections and Infestations Acute hepatitis B, Acute hepatitis C
Conditions
Interventions
Current interventions as of 06/02/2014:
Screening of hard-to-reach individuals, random allocation of those infected with HCV to either peer support and accompanied referrals or normal
Sponsors
University College London (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Homeless or substance misusing individuals
Exclusion criteria
Exclusion criteria: 1. Individuals unable to give informed consent 2. Under 16 years of age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 06/12/2012: 1. Cost effectiveness evaluation of the interventions 2. Successfully reaching an appropriate clinical endpoint for those HCV infected Previous primary outcome measures until 06/12/2012: 1. Cost effectiveness evaluation of the interventions 2. Successful completion of full HCV clinical diagnosis | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 06/12/2012: 1. Sustained virological response to HCV treatment 2. Successfully reaching an appropriate clinical endpoint, full diagnosis and commencement of treatment, where appropriate, for those HBV infected 3. Proportion of hard-to-reach with adequate immune response to HBV vaccine 4. Factors influencing lack of vaccine uptake Previous secondary outcome measures until 06/12/2012: 1. Sustained virological response to HCV treatment 2. Successful full HBV clinical diagnosis and commencement of treatment 3. Proportion of hard-to-reach with adequate immune response to HBV vaccine 4. Factors influencing lack of vaccine uptake | — |
Countries
United Kingdom
Outcome results
None listed